Benign Paroxysmal Positional Vertigo

Benign Paroxysmal Positional Vertigo

National Organization for Rare Disorders, Inc.

Important

It is possible that the main title of the report Benign Paroxysmal Positional Vertigo is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Synonyms

  • BPPV

Disorder Subdivisions

  • None

General Discussion

Summary

Benign paroxysmal position vertigo (BPPV) is a disorder characterized by brief, recurrent bouts of vertigo. Vertigo is a sensation of spinning, whirling or turning. Individuals often feel as if the room is moving or spinning and they can lose their balance and have difficulty standing or walking. Affected individuals often have abnormal eye movements as well (nystagmus). BPPV is most often triggered by rapid, sometimes unexpected changes in head position. The severity of the disorder varies. In some cases, it only causes mild symptoms, while in others it can potentially cause more severe, even debilitating symptoms. BPPV may disappear on its own only to return weeks or months later. Most affected individuals can be easily and effectively treated by non-invasive methods such as canalith (or canalolith) repositioning maneuvers. However, BPPV may recur even after effectively treated. BPPV is believed to be caused by the displacement of small calcium carbonate crystals within the inner ear. These tiny crystals become dislodged from their normal location and fall into one of three semicircular canals, which are tiny, interconnected, looped tubes that can detect movements of the head and that play a role in helping the body maintain balance. The exact, underlying cause of this displacement is not always known (idiopathic). Recurrences are possible because additional calcium can become dislodged. The treatment maneuvers remove the calcium but do not prevent the shedding of additional calcium crystals in the future.



Introduction

BPPV has been identified as a clinical entity since the late 1800s. The term benign means that the disorder is not progressive and is not considered serious. Although labeled benign, BPPV can disrupt a person's daily activities and affect quality of life. The term paroxysmal means that episodes arise suddenly and often unpredictably. The term positional means the disorder is contingent on a change of the position of the head.

BPPV is one of the most common causes of vertigo.

Symptoms

The onset of an episode of BPPV is usually sudden following a rapid or sometimes unexpected change in head position. Often, ordinary movements such as turning over on one's side, lying down, looking up or stooping or bending over can cause an episode. The severity of the disorder can vary greatly from one person to another. Factors that may affect the severity include the speed of head movement, the volume of calcium crystals that are moved, and a person's innate sensitivity to motion. For some people, only a slight positional change of the head can cause symptoms. In such cases, this extreme sensitivity can cause near constant vertigo. In other individuals, the disorder despite a rapid change of head position may only produce mild symptoms. In some cases, symptoms may only be caused by very precise, specific movements. The duration of symptoms of BPPV may also vary and can potentially persist for days, weeks, or months or become recurrent over many years.



Vertigo in individuals with BPPV usually lasts less than 60 seconds. Vertigo can lead to unsteadiness and a loss of balance. Additional symptoms can develop including lightheadedness, dizziness, nausea, vomiting, and blurred vision. Nausea or a feeling of queasiness can persist for a short time even after the sensation of vertigo has passed.



A common associated finding with BPPV is nystagmus, an eye disorder characterized by rapid, involuntary movements of the eye. The eyes may be described as jumping or twitching in certain directions. Nystagmus associated with BPPV is fatigable meaning that if one repeats the position change that induced the original vertigo and nystagmus, after time nystagmus lessens in frequency and severity. Therefore, nystagmus tends to be worse in the morning and improves throughout the day.



The type of nystagmus, defined by the direction of the abnormal eye movements, can vary depending upon which of the three semicircular canals of the inner ear is involved. The three canals are known as the posterior, horizontal and anterior canals. Some researchers subdivide BPPV into posterior BPPV, horizontal BPPV and anterior BPPV based on the specific canal involved. Most cases of BPPV involve the posterior canal, which is also referred to as classic BPPV. Other symptoms such as the severity or duration of vertigo can be related to which specific canal is involved.

Causes

In some cases, the exact underlying cause of BPPV is unknown (idiopathic). Researchers believe that most cases of BPPV are caused by abnormalities affecting the inner ear. The inner ear contains the cochlea, which converts sound pressure from the outer ear into nerve impulses that are sent to the brain via the auditory canal. The inner ear also contains the semicircular canals. Fluid moves through these canals enabling the brain to detect movements of the head.



Two additional structures found in the inner ear are the utricle and saccule (otolith organs). The utricle and saccule are fluid-filled sacs or cavities that monitor the various movements of one's head and detect the head's position in relation to gravity. The utricle and saccule contain small calcium carbonate crystals. For unknown reasons, in individuals with BPPV these crystals become dislodged and fall into the semicircular canals. Within the canals, these crystals may stimulate nerve endings called cupula, resulting in the body being sensitive to certain head position changes that normally would not cause a response. Basically, the brain is sent powerful asymmetric nerve signals that resemble the kind of asymmetry associated with spinning. This gives a patient the same sensation that would occur with spinning.



Two specific theories proposed in regard to the underlying cause of BPPV are the canalithiasis and cupulolithiasis theories. These proposed mechanisms are not mutually exclusive and there is scientific evidence that both occur, but that canalithiasis is more common than cupulolithiasis. Canalithiasis refers to calcium crystals that are freely mobile within the semicircular canals and, whenever the head changes position, these crystals move through the canal. As these crystals move, they are believed to drag the fluid within the canals, known as endolymph, behind them. As the endolymph moves through the canals, it stimulates the hair cells of the cupula causing vertigo and nystagmus. When the head is not moving, the crystals (and therefore the endolymph) do not move as well. Consequently, there is no stimulation of the cupula and no associated vertigo or nystagmus. It is believed that these crystals eventually dissolve or fall back into the vestibule (the cavity at the entrance to one of the canals). Canalithiasis appears to best explain most cases of BPPV.



Cupulolithiasis refers to crystals that have become stuck (adhered) to the cupula in one of the three semicircular canals, usually the posterior canal. BPPV caused by cupulolithiasis is believed to account for the more persistent cases of BPPV that do not respond as well to positioning treatments.



Neither the canalithiasis nor the cupulolithiasis theories address why the crystals become dislodged. There are many different theories as to what conditions can cause crystals to become dislodged and enter the semicircular canals. Such conditions include head trauma, surgery, chronic middle ear infections (otitis media), a severe cold or infection, and other ear disorders such as Meniere's disease or vestibular neuritis.



Additional factors that may predispose individuals to BPPV include alcoholism, inactivity, age, and certain central nervous system disorders. In many cases, no such precipitating cause can be identified (idiopathic).

Affected Populations

The lifetime prevalence of BPPV is about 2.4% and other estimates range from 10-64 per 100,000 people in the general population. However, many physicians believe that the disorder is often misdiagnosed and that the true frequency may be higher. BPPV most often affects older adults with a peak age of onset in the sixth decade. The disorder may affect individuals of any age, but is quite uncommon in those under 20 years of age. Women are believed to be affected at least twice as often as men.

Standard Therapies

Diagnosis

A diagnosis of BPPV is based upon identification of characteristic symptoms, a detailed patient history and a thorough clinical evaluation. Affected individuals usually have a history of episodes of vertigo.



Clinical Testing and Work-Up

Affected individuals will undergo a Dix-Hallpike test. During this test, an affected individual sits down, with legs extended, on an examination table. The doctor will rotate the head approximately 30 to 45 degrees and then help the person quickly lie on his or her back (supine position). In individuals with BPPV, this will prompt a characteristic episode of nystagmus and/or vertigo. The timing and appearance of the eye movements will help a physician determine the cause of vertigo. The Dix-Hallpike test can differentiate vertigo caused by a problem in the brain from vertigo caused by a problem in the inner ear. The specific pattern of nystagmus will tell a physician which of the three semicircular canals of the inner ear is involved in an individual case.



In some cases in which a diagnosis is in doubt, affected individuals may undergo a test such as magnetic resonance imaging (MRI) to rule out other conditions. An MRI uses a magnetic field and radio waves to produce cross-sectional images of particular organs and bodily tissues such as in the brain or ear.



In some cases, a physician may use a test called electronystagmography (ENG) or videonystagmography (VNG), which records the voluntary and involuntary movements of the eyes. During this exam, electrodes are placed around the eyes (ENG) or goggles with cameras are placed over the eyes (VNG). Both techniques record eye movements following different stimuli such as staring at a light, moving the head to different positions, and stimulating the inner ear and nearby tissue, usually by cold or warm water (or air). The information can then be analyzed by a computer and this can determine if there is a disturbance in the normal functioning of the inner ear balance.



Treatment

Individuals with BPPV may be treated with canalith repositioning maneuvers, in which the head is put through a series of specific movements designed to shift the crystals (otoliths) out of the semicircular canals and back into the vestibule. Once the crystals are back in the vestibule, they are usually reabsorbed in a matter of days. The maneuvers may need to be repeated. Different maneuvers are required depending upon which of the three semicircular canals are involved. Canalith repositioning maneuvers are often highly effective in treating BPPV, although the condition can recur often within one year. Canalith repositioning maneuvers are initially performed at a physician's office, but affected individuals may be taught the maneuvers in to order to perform them at home. During therapy, crystals may occasionally move from one semicircular canal to another, which is referred to as canal switch.



The Epley maneuver is a common canalith repositioning maneuver. The Epley maneuver is a five position cycle that is repeated until no signs of nystagmus are observed. Patients are placed in a sitting position on an examination table with their head turned 45 degrees toward the affected ear. Patients are then tilted back onto the table with their head hanging off the end. The head is then slowly rotated toward the unaffected ear. Patients are then rolled onto their side and the head is rotated back toward the affected ear. The patient is then brought back to a sitting position. Canalith repositioning maneuvers like the Epley maneuver are relatively simple, noninvasive and effective therapy for individuals with BPPV. Other canal repositioning maneuvers used to treat individuals with BPPV include the Semont liberatory maneuver and for the less common horizontal canal variant of BPPV, the Lempert maneuver. These maneuvers may have slight variations as well.



In some cases, affected individuals may be referred for vestibular rehabilitation therapy (VRT). VRT is the use of specific exercises that are designed to compensate for inner ear deficiencies. While this technique may coincidentally improve BPPV, it is really intended to promote adaptation by the brain to loss of balance function related to inner ear on one side. A physical or occupational therapist will develop a treatment plan tailored to an individual based upon a thorough examination. Basically, affected individuals will perform a series of exercises or postures that over time will lessen their symptoms. Initially, the exercises may temporarily worsen symptoms. However, if affected individuals persist with their instructions, VRT often leads to a decrease in symptom severity or complete disappearance of symptoms. In some cases, no other therapy is necessary.



The Brandt-Daroff exercise is often used to treat individuals with BPPV. Individuals begin this exercise in a seated, upright position and then lie down on their sides with their noses pointed upward at about a 45 degree angle. Individuals will remain in this position for 30 seconds or less if the the vertigo stops. Individuals will then return to a seated position and then repeat the exercise on the other side. Affected individuals may be instructed to do 20 repetitions of this exercise twice a day. Symptoms often improve gradually over a few weeks. This exercise is somewhat similar to but less effective than the Semont maneuver in clinical trials.



Some individuals with BPPV may opt for watchful watching. During watchful waiting, individuals do not receive any active treatment and simply wait out the episodes since in many cases BPPV is a self-limiting disorder. During watchful waiting, affected individuals are cautioned to avoid activities that could trigger or worsen BPPV such as bending down to pick something up or extending one's head. However, since symptom resolution can take weeks or months, many individuals opt for treatment rather than watchful waiting.



Some affected individuals may receive medications called vestibular suppressants (e.g., antihistamines or benzodiazepine) that may help relieve certain symptoms of BPPV such as the spinning sensation or nausea. However, drug therapy for BPPV itself is generally ineffective and usually not recommended because canalith repositioning maneuvers are so effective.



In rare cases, individuals with BPPV may be treated with surgery. The frequency of surgery as a treatment for BPPV has dropped in recent years. Surgery for BPPV is reserved for individuals who fail to respond to less invasive treatment options and for whom symptoms are recurrent and problematic (intractable BPPV). The most common procedure used is plugging (occluding) the posterior semicircular canal in order to prevent crystals from causing deflection and stimulation of the cupula. Another procedure, called singular neurectomy, has also been discussed in the medical literature as a potential therapy for intractable BPPV. During a singular neurectomy, a surgeon cuts a specific nerve to the posterior semicircular canal, thereby eliminating the abnormal signals being transmitted from the inner ear. This causes symptoms to improve. However, single neurectomy is a difficult procedure and is rarely performed because it carries a risk of hearing loss. Canal plugging is used more often in the rare cases that require surgical intervention. Although it also has a risk of associated hearing loss, the hearing loss is usually temporary (transient). Surgical therapy is not considered for BPPV except as a last resort.

Investigational Therapies

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.



For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:



Toll-free: (800) 411-1222

TTY: (866) 411-1010

Email: prpl@cc.nih.gov



For information about clinical trials sponsored by private sources, in the main, contact:

www.centerwatch.com.

References

JOURNAL ARTICLES

Hornibrook J. Benign paroxysmal positional vertigo (BPPV): history, pathophysiology, office treatment and future directions. Int J Otolaryngol. 2011; Epub Jul 25. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144715/?tool=pubmed



Riga M, Bibas A, Xenellis J, Korres A. Inner ear disease and benign paroxysmal positional nystagmus: a critical review of incidence, clinical characteristics, and management. Int J Otolaryngol. 2011;Epub 2011 Aug. 2. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151504/pdf/IJOL2011-709469.pdf



Cohen HS, Sangi-Haghpevkar H. Canalith repositioning variations for benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2010;143:405-412. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925299/pdf/nihms204567.pdf



Lee SH, Kim JS. Benign paroxysmal positional vertigo. J Clin Neurol. 2010;6:51-63.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895225/pdf/jcn-6-51.pdf



Fife TD. Benign paroxysmal positional vertigo. Semin Neurol. 2009;29:500-508. https://www.thieme-connect.com/ejournals/pdf/sin/doi/10.1055/s-0029-1241041.pdf



Levenque M. Labrousse M, Seidermann L, Chays A. Surgical therapy in intractable benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2007;136:693-698.



von Brevern M, Radtke A, Lezius F, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78:710-715. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117684/?tool=pubmed



Hilton M, Pinder D. Benign paroxysmal positional vertigo. A safe and effective treatment is available for this well defined condition. BMJ. 2003;326:673. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1125587/pdf/673.pdf



Fife TD, Iverson J, Lempert T, et al. Practice parameters: therapies for benign paroxysmal positional vertigo (an evidence-based review: report of the Quarterly Standards Subcommittee of the American Academy of Neurology. Neurology. 2008;70:2067-2074.



FROM THE INTERNET

Li J, Meyers AD. Benign paroxysmal positional vertigo. Emedicine Journal, March 18, 2010. Available at: http://emedicine.medscape.com/article/884261-overview Accessed on: August 10, 2011.



Mayo Clinic for Medical Education and Research. Benign Paroxysmal Positional Vertigo. May 15, 2010. Available at: http://www.mayoclinic.com/health/vertigo/DS00534 Accessed On: August 10, 2011.

Resources

Vestibular Disorders Association

PO Box 13305

Portland, OR 97208-4467

USA

Tel: (503)229-7705

Fax: (503)229-8064

Tel: (800)837-8428

Email: veda@vestibular.org

Internet: http://www.vestibular.org



American Nystagmus Network, Inc.

303-D Beltline Place, #321

Decatur, AL 35603

USA

Email: bduck@nystagmus.org

Internet: http://www.nystagmus.org



American Academy of Audiology

11730 Plaza America Drive, Suite 300

Reston, VA 20190

Tel: (703)790-8466

Fax: (703)790-8631

Tel: (800)222-2336

Email: infoaud@audiology.org

Internet: http://www.audiology.org



For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use . How this information was developed to help you make better health decisions.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.